drugset / Trial / NCT00520741
Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this historical-controlled trial is to demonstrate the efficacy and safety of conversion to Lacosamide monotherapy in subjects with Partial-onset Seizures who are withdrawn from 1 to 2 marketed antiepileptic drugs.
Timeline
- Start
- 2007-08
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lacosamide | Other / unclassified | 300 mg | — |
| Comparator | Lacosamide | Other / unclassified | 400 mg | — |